Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
Merck's COVID-19 Pill works Against Omicron, Lab Studies Show
January 28, 2022
Tickers
MRK
From Benzinga
CHMP Recommends Pfizer's Paxlovid For Use In Adults With COVID-19
January 27, 2022
Tickers
PFE
From Benzinga
From Benzinga
Aridis Shares Rise On Funding For Inhaled Monoclonal Antibodies Against Influenza, COVID-19
January 27, 2022
Tickers
ARDS
From Benzinga
From Benzinga
iBio Advances Its Vaccine Program for Multi-Variant COVID-19 Disease
January 26, 2022
Tickers
IBIO
From Benzinga
NRx Receives Initial Report of Patient Safety From 'Right To Try' Use Of Zyesami For COVID-19
January 26, 2022
Tickers
NRXP
From Benzinga
From Benzinga
Pfizer, BioNTech Launch Omicron-Targeted COVID-19 Vaccine Trial
January 25, 2022
From Benzinga
Britain To Test Merck - Ridgeback Biotherapeutics' COVID-19 Antiviral Pill In Hospitalized Patients
January 24, 2022
Tickers
MRK
From Benzinga
Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows
January 24, 2022
From Benzinga
On Positive Virology Data, SAB Biotherapeutics' COVID-19 Drug To Move To Phase 3 In NIH ACTIV-2 Trial
January 24, 2022
Tickers
SABS
From Benzinga
Arcturus Therapeutics' COVID-19 Booster Clinical Trial Show Encouraging Neutralizing Antibody Responses
January 24, 2022
From Benzinga
FDA Approves Gilead's Remdesivir For Non-Hospitalized COVID-19 Patients At High Risk For Disease Progression
January 24, 2022
Tickers
GILD
From Benzinga
Tennis Player Novak Djokovic Holds Majority Stake In European Biotech Working On COVID-19 Treatment
January 21, 2022
From Benzinga
From Benzinga
Sputnik V Associated With Higher Antibody Levels Against Omicron Than Pfizer, Study Shows: Reuters
January 20, 2022
From Benzinga
Three doses of Valneva's COVID-19 Vaccine Neutralizes Omicron Variant, Lab Study Shows
January 19, 2022
From Benzinga
NRx Pharma's Zyesami Access Expanded To COVID-19 Patients Who Exhausted All Approved Treatments
January 18, 2022
Tickers
NRXP
From Benzinga
Pfizer To Boost Output For COVID-19 Oral Treatment With Novasep Deal
January 18, 2022
Tickers
PFE
From Benzinga
Canada Approves Pfizer's At-Home COVID-19 Antiviral Treatment, But Deliveries Delayed
January 18, 2022
From Benzinga
From Benzinga
From Benzinga
Johnson and Johnson' COVID-19 Booster Is 85% Effective Against Omicron Hospitalization, South African Study Shows
January 14, 2022
Tickers
JNJ
From Benzinga
RedHill Biopharma's Oral COVID-19 Treatment Improves Median Time To Viral RNA Clearance
January 13, 2022
Tickers
RDHL
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.